Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

More From Author

Apart from Puja and prasadam, high tea takes the centre stage during the Navaratri festival in Chennai

The Lords of the Fallen sequel is officially in development, with a Sniper Ghost Warrior installment on the way too

Leave a Reply

Your email address will not be published. Required fields are marked *